GLN-OLMESARTAN
Identification of Gln-Olmesartan
| No description |
Google image searchProduct monograph
Active ingredient
olmesartan medoxomil, 20 MG
DIN: 02469812
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 05-MAR-2019
ATC:
- C09 — AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM (ATC, ATC/DDD, )
- C09C — ANGIOTENSIN II ANTAGONISTS, PLAIN (ATC, ATC/DDD)
- C09CA — Angiotensin II antagonists, plain (ATC, ATC/DDD)
- C09CA08 — OLMESARTAN MEDOXOMIL (ATC/DDD)
Reference brand drug: Olmetec
